Adolor Corporation (ADLR) and GlaxoSmithKline (GSK) Announce FDA Advisory Committee Review for New Drug
Adolor Corporation (ADLR) and GlaxoSmithKline (GSK) have jointly announced that the Gastrointestinal Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) will review Adolor's application for the new drug, Entereg. This drug can accelerate the time it takes for pain to dissipate after large or small bowel resection surgery with minimal intrusion. Adolor Corporation (ADLR) is a biopharmaceutical company specializing in the discovery, development, and commercialization of pain management products. Adolor has a large number of discovery and clinical research programs that are focused on the various treatments of pain. Adolor is seeking to make a positive difference…